China Dasheng Biotechnology Company
CDBT
Other OTC0.10
USD
- -
- -
CIK
0001393067
ISIN
US16944C1080
Return %
Stock
S&P500
1Y
35.14
26.53
3Y
-33.33
76.60
5Y
900.00
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Gang Chen
- Full Time Employees
- 689
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- Building B Lanzhou People's Republic of China
- IPO Date
- Feb 13, 2008
- CIK
- 0001393067
- Website
- chinadashengbio.com
- Similar Companies
- Business
- China Dasheng Biotechnology Company engages in the research, development, manufacture, and sale of biotechnology products primarily for the veterinary and agricultural markets. Its core product portfolio includes diagnostic reagents, immunoassay kits, and vaccines designed to detect and prevent infectious diseases in livestock and companion animals, along with veterinary feed additives, nutrient supplements, enzyme preparations, and probiotics aimed at improving animal growth performance and disease resistance. The company’s offerings are marketed mainly within China’s domestic market and to regional customers, targeting feed manufacturers and livestock producers. Founded in 2008 and headquartered in Scottsdale, Arizona, China Dasheng Biotechnology is also involved in new geometric configuration low carbon emission clean technology solutions through its recent acquisition of Cycclone Magnetic Engines, Inc., which extends its business into clean energy, including permanent magnet engines and related technology with transport operations in Australia. In 2023, China Dasheng Biotechnology terminated a consulting agreement due to non-performance and strategically acquired Cycclone Magnetic Engines to pivot towards clean technology innovation alongside its core biotechnology business. The company continues to explore collaborations and product pipeline advancements to address animal health challenges and environmental sustainability.
CDBT Registers Magistrates Court of Queensland Judgments against Kenneth Maciora / Empire Relations Group
CDBT - Terminates Consulting Agreement with Kenneth Maciora / Empire Relations Group
CDBT - Cycclone Magnetic Engines